Remote glucose monitoring of patients isolated during the Covid-19 pandemic
- Funded by Novo Nordisk Foundation
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Known Financial Commitments (USD)
$176,920.8Funder
Novo Nordisk FoundationPrincipal Investigator
N/A
Research Location
DenmarkLead Research Institution
Department of Endocrinology & Nephrology, Nordsjællands HospitalResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Supportive care, processes of care and management
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Hospital personnel
Abstract
The purpose of the project is to provide hospital staff with real-time insights into the development of blood glucose levels in COVID-19 patients and isolated diabetes patients through wireless glucose meters transmitting continual readings. Normally, hospitalized patients have their glucose level measured five times a day using traditional point-of-care equipment. Remote glucose monitoring of patients will reduce the need for protective equipment and save staff resources, and it enables fast intervention if the glucose level is either too high or too low.